More importantly, KCs derived from Ccl8-knockout mice, even pretreated with LvM16 cancer cells, demonstrated a much weaker capacity to activate neutrophils than the wild-type (WT) counterpart (Fig. 4f). Here, CCL8 is linked to cancer.